7 Best Stocks for the Next 30 Days

Get them in a free Special Report, and get more Zacks Insights in our free e-newsletter, Profit from the Pros. Every issue includes a fresh Zacks #1 Bull Stock of the Day.

Close This Panel X

Are you a new Zacks Member or a visitor to Zacks.com?

Recent Quotes

No Recent Quote currently available

My Portfolio

My Portfolio Tracker

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Stocks on the Move 05/22/2013

Company Name Symbol %Change
ALLIANCE FIB AFOP
14.22%
TRI TECH HOL TRIT
10.00%
A M R CP AAMRQ
9.04%
JAZZ PHARMAC JAZZ
5.48%
SANTARUS INC SNTS
5.02%

DeVry, Inc.: A Strong Buy

by Zacks Equity Research

December 31, 2012 | Comments : 0 Recommended this article: (0)

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

Rising earnings estimates on the back of strong first-quarter fiscal 2013 results, which included a 58.1% earnings surprise, helped this diversified education provider DeVry, Inc. ( DV - Analyst Report ) achieve a Zacks #1 Rank (Strong Buy) on December 29. This stock turned around from past few quarterly results and has bright prospects going forward.

The stock is currently trading at 80.9% discount to its 52-week high of $42.37. With a discounted price and long-term expected earnings growth rate of 9.8%, this stock offers an attractive investment opportunity.

The Rank Drivers

Combination of a solid cost-control strategy, improving new student enrollments, brand building and growth investments and an upbeat outlook are the rank drivers for this stock.

On October 25, DeVry reported first-quarter fiscal 2013 (ended September 30) earnings of 49 cents per share, largely beating the Zacks Consensus Estimate of 31 cents by 58%. Higher-than-expected cost savings and improving new student enrollments at several institutions drove the earnings beat.

Continued progress on its performance improvement plan to align costs, regain enrollment growth and make growth investments helped the company to turnaround from the past few weak quarterly results.

Revenue of $482.7 million also beat the Zacks Consensus Estimate of $481 million primarily driven by better-than-expected new enrollment growth at the medical institutions. Though post-secondary enrollments across all its programs declined year over year, the company witnessed solid new enrollment growth in healthcare institutions like Chamberlain College of Nursing and Carrington Colleges. The sequential improvement in new enrollments at DeVry University is also an encouraging sign.

Operating costs declined both year over year and sequentially owing to DeVry’s cost saving initiatives. Though near-term results are expected to remain choppy due to continued enrollment declines at the flagship DeVry University, we believe that the company has a solid plan to reduce costs and drive attractive earnings growth in the 2014-2016 period.

Earnings Estimates Rising

Over the last 60 days, the Zacks Consensus Estimate for fiscal 2013 has increased 2.4% to $2.16 per share, as all the 14 estimates were revised higher. The Zacks Consensus Estimate for fiscal 2014 has risen 0.8% to $2.45 per share, with 12 out of 14 estimates going up over the same time frame, reflecting a year-over-year increase of 13.6%.

Valuation

DeVry looks expensive at current levels. DeVry currently trades at a forward price-to-earnings (P/E) of 11.01, representing a premium of 42.2% to the peer group average of 7.74. On a price-to-sales basis too, the stock is trading at 0.73, a premium of 73.8% to the peer group average of 0.42.

However, the shares trade at a discount of 9.8% to the peer group on a price-to-book value basis. Overall, the premium valuation looks justified given its strong fundamentals.

About the Company

DeVry provides secondary and post-secondary education primarily in the U.S. and also has operations in Canada, some Caribbean countries, Brazil, Europe, the Middle East and the Pacific Rim. The company’s programs focus mainly in the fields of business, healthcare and technology.

The company also serves accounting and finance professionals. The market cap of the company is $1.5 billion. DeVry, a peer of Apollo Group ( APOL - Analyst Report ) , carries a Zacks #3 Rank (short term Hold rating).

Email Print Share Rate Pos Rate Neg

Read/Post Comments (0) | Recommended this article (0)

Please login to Zacks.com or register to post a comment.

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.